monoclonal antibody therapy | sciencenewsnet.in

Breaking News

Moffitt Research Advocates for Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients

CDC Reports a Rise in Flu Cases

Cell painting technology holds promise for drug discovery

Cathy Wood Named Inaugural Vice Dean for Finance and Administration at the Johns Hopkins University School of Medicine

GW Report on Wildfire Resilience: Unprecedented LA Wildfires Highlight Urgency of New Resilience Framework

Expert Available: Trump’s Aggressive Economic Tactics Reshape U.S. Foreign Policy, Sparking Global Uncertainty

Expert Available: DeepSeek’s AI Breakthrough Redefines Global Competition and Challenges U.S. Tech Policy

American Chiropractic Association Presents 2025 Annual Awards

Gottlieb Memorial Named Among Best Nursing Homes in Illinois by U.S. News & World Report

Argonne releases Aurora exascale supercomputer to researchers, enabling accelerated science

29 Jan, 2025

MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease

December 10, 2024 sarah JonasAnnouncement

MD Anderson and AmMax Bio announced agreements to develop and advance AmMax’s AMB-066 monoclonal antibody therapy for colorectal cancer with minimal residual disease.

Targeting Molecular Pathway that Causes Pulmonary Arterial Hypertension

May 6, 2022 sarah JonasResearch Results

UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.